Testosterone and body functions

Aging Male

Volumn 9, Issue 4, 2006, Pages 183-188

  Köhn, Frank Michael ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b Andrologicum München ^*  (Germany)

Author keywords

Body composition; Bone; Hypogonadism; Metabolic disorders; Testosterone

Indexed keywords

ALKALINE PHOSPHATASE; OSTEOCALCIN; PARATHYROID HORMONE; PROCOLLAGEN; TESTOSTERONE;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANDROGEN DEFICIENCY; ATHEROGENESIS; BODY COMPOSITION; BODY FAT DISTRIBUTION; CONFERENCE PAPER; CORONARY ARTERY DISEASE; CORONARY RISK; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; HORMONAL REGULATION; HUMAN; HYPOGONADISM; METABOLIC SYNDROME X; MUSCLE STRENGTH; NUCLEAR MAGNETIC RESONANCE IMAGING; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIDE EFFECT; TESTOSTERONE BLOOD LEVEL; TESTOSTERONE SYNTHESIS; THERAPY EFFECT; TIBIA;

AGED; AGING; BODY COMPOSITION; BONE AND BONES; HUMANS; HYPOGONADISM; MALE; METABOLIC DISEASES; TESTOSTERONE;

EID: 33845725076     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.1080/13685530601060396     Document Type: Conference Paper

References (27)

1. World Health Organization. Men, ageing and health. Aging Male 2000;3:3-36.
2. Kohn FM, Schuppe HC, Schill WB, Elbers J. Treatment of late onset hypogonadism with a new formulation of testosterone undecanoate - baseline data of a multicenter study. Andrologia 2004;36:174-175.
3. Devogelaer JP, De Cooman S, Nagant de Deuxchaisnes C. Low bone mass in hypogonadal males. Effect of testosterone substitution therapy, a densitometric study. Maturitas 1992;15:17-23.
4. Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 1996;81:4358-4365.
5. Wang C, Cunningham G, Dobs A, Iranmanesh A,Matsumoto AM, Snyder PJ, Weber T, Berman N, Hull L, Swerdloff RS. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 2004;89:2085-2098.
6. Benito M, Vasilic B, Wehrli FW, Bunker B, Wald M, Gomberg B, Wright AC, Zemel B, Cucchiara A, Snyder PJ. Effect of testosterone replacement on trabecular architecture in hypogonadal men. J Bone Miner Res 2005;20:1785-1791.
7. Dean JD, Carnegie C, Rodzvilla J. Long-term effects of Testim 1% testosterone gel in hypogonadal men. Rev Urol 2004;6(Suppl. 6):S22-S29.
8. Sinha-Hikim I, Artaza J, Woodhouse L, Gonzalez-Cadavid N, Singh AB, Lee MI, Storer TW, Casaburi R, Shen R, Bhasin S. Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. Am J Physiol Endocrinol Metab 2001;283:E154-E164.
9. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Lenrow DA, Holmes JH, Dlewati A, Santanna J, Rosen CJ, Strom BL. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 1999;84:2647-2653.
10. Burris AS, Banks SM, Carter CS, Davidson JM, Sherins RJ. A long-term, prospective study of the physiologic and behavioral effects of hormone replacement in untreated hypogonadal men. J Androl 1992;13:297-304.
11. Sih R, Morley JE, Kaiser FE, Perry HM 3rd, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 1997;82:1661-1667.
12. Bhasin S, Storer TW, Berman N, Yarasheski KE, Clevenger B, Phillips J, Lee WP, Bunnell TJ, Casaburi R. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab 1997;82:407-413.
13. Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T, Berman N. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab 2000;85:2839-2853.
14. Urban RJ, Bodenburg YH, Gilkison C, Foxworth J, Coggan AR, Wolfe RR, Ferrando A. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol 1995;269:E820-826.
15. Bouloux P. Testim 1% testosterone gel for the treatment of male hypogonadism. Clin Ther 2005;27:286-298.
16. McNicholas TA, Dean JD, Mulder H, Carnegie C, Jones NA. A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function. BJU Int 2003;91:69-74.
17. Pitteloud N, Mootha VK, Dwyer AA, Hardin M, Lee H, Eriksson KF, Tripathy D, Yialamas M, Groop L, Elahi D, Hayes FJ. Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care 2005;28:1636-1642.
18. Rhoden EL, Ribeiro EP, Teloken C, Souto CA. Diabetes mellitus is associated with subnormal serum levels of free testosterone in men. BJU Int 2005;96:867-870.
19. Tibblin G, Adlerberth A, Lindstedt G, Bjorntorp P. The pituitary-gonadal axis and health in elderly men: a study of men born in 1913. Diabetes 1996;45:1605-1609.
20. Haffner SM, Shaten J, Stern MP, Smith GD, Kuller L. Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Am J Epidemiol 1996;143:889-897.
21. Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 2000;23:490-494.
22. Oh JY, Barrett-Connor E, Wedick NM, Wingard DL. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care 2002;25:55-60.
23. Svartberg J, Jenssen T, Sundsfjord J, Jorde R. The associations of endogenous testosterone and sex hormone-binding globulin with glycosylated hemoglobin levels, in community dwelling men. The Tromso Study. Diabetes Metab 2004;30:29-34.
24. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 2004;27:1036-1041.
25. Boyanov MA, Boneva Z, Christov VG. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male 2003;6:1-7.
26. Kohn FM, Ring J, Schill WB. [Dermatologic aspects of male hypogonadism]. Hautarzt 2000;51:223-230.
27. O'Connor DB, Archer J, Wu FC. Effects of testosterone on mood, aggression, and sexual behavior in young men: a double-blind, placebo-controlled, cross-over study. J Clin Endocrinol Metab 2004;89:2837-2845.